Vincerx Historical Balance Sheet

VINC Stock  USD 0.26  0.01  4.00%   
Trend analysis of Vincerx Pharma balance sheet accounts such as Total Assets of 17.3 M, Other Current Liab of 744.8 K, Total Current Liabilities of 7.5 M or Total Stockholder Equity of 10.7 M provides information on Vincerx Pharma's total assets, liabilities, and equity, which is the actual value of Vincerx Pharma to its prevalent stockholders. By breaking down trends over time using Vincerx Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Vincerx Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vincerx Pharma is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.

About Vincerx Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Vincerx Pharma at a specified time, usually calculated after every quarter, six months, or one year. Vincerx Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Vincerx Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Vincerx currently owns. An asset can also be divided into two categories, current and non-current.

Vincerx Pharma Balance Sheet Chart

At present, Vincerx Pharma's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 2.3 M, whereas Total Assets are forecasted to decline to about 17.3 M.

Total Assets

Total assets refers to the total amount of Vincerx Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vincerx Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Vincerx Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Vincerx Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Vincerx Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Vincerx Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Term Investments

Short Term Investments is an item under the current assets section of Vincerx Pharma balance sheet. It contains any investments Vincerx Pharma undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Vincerx Pharma can easily liquidate in the marketplace.
Most accounts from Vincerx Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Vincerx Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.At present, Vincerx Pharma's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 2.3 M, whereas Total Assets are forecasted to decline to about 17.3 M.
 2021 2022 2023 2024 (projected)
Other Current Liabilities10.4M3.0M784K744.8K
Total Assets117.7M59.3M18.2M17.3M

Vincerx Pharma balance sheet Correlations

0.60.921.00.9-0.370.620.790.010.70.90.710.91.00.61.00.6-0.190.630.760.42-0.010.01-0.33-0.1-0.2
0.60.40.630.520.020.090.10.110.330.680.170.340.630.010.640.01-0.180.020.20.2-0.110.11-0.180.120.1
0.920.40.890.97-0.70.820.94-0.350.880.930.91.00.890.830.880.830.140.880.640.090.3-0.35-0.09-0.46-0.54
1.00.630.890.88-0.320.570.750.050.660.890.660.881.00.551.00.55-0.240.570.770.46-0.050.05-0.36-0.05-0.14
0.90.520.970.88-0.680.740.89-0.40.880.950.880.960.880.80.870.80.110.830.610.030.4-0.4-0.12-0.49-0.5
-0.370.02-0.7-0.32-0.68-0.88-0.760.77-0.91-0.6-0.9-0.71-0.32-0.92-0.3-0.92-0.75-0.93-0.020.62-0.80.77-0.520.950.96
0.620.090.820.570.74-0.880.84-0.420.930.710.950.840.570.920.560.920.590.930.2-0.290.48-0.420.44-0.71-0.86
0.790.10.940.750.89-0.760.84-0.410.850.760.940.950.750.930.730.930.180.940.650.020.46-0.41-0.06-0.56-0.6
0.010.11-0.350.05-0.40.77-0.42-0.41-0.53-0.33-0.5-0.350.05-0.540.08-0.54-0.65-0.610.160.77-0.81.0-0.350.860.73
0.70.330.880.660.88-0.910.930.85-0.530.850.970.880.660.930.640.930.540.920.25-0.330.61-0.530.34-0.76-0.82
0.90.680.930.890.95-0.60.710.76-0.330.850.790.910.890.670.890.670.140.720.490.040.25-0.33-0.06-0.4-0.46
0.710.170.90.660.88-0.90.950.94-0.50.970.790.910.660.980.650.980.470.970.37-0.250.6-0.50.26-0.74-0.8
0.90.341.00.880.96-0.710.840.95-0.350.880.910.910.880.850.860.850.140.890.650.090.31-0.35-0.09-0.47-0.55
1.00.630.891.00.88-0.320.570.750.050.660.890.660.880.551.00.55-0.240.570.770.46-0.050.05-0.36-0.05-0.14
0.60.010.830.550.8-0.920.920.93-0.540.930.670.980.850.550.531.00.490.980.35-0.30.68-0.540.28-0.79-0.82
1.00.640.881.00.87-0.30.560.730.080.640.890.650.861.00.530.53-0.250.550.760.47-0.080.08-0.37-0.02-0.12
0.60.010.830.550.8-0.920.920.93-0.540.930.670.980.850.551.00.530.490.980.35-0.30.68-0.540.28-0.79-0.82
-0.19-0.180.14-0.240.11-0.750.590.18-0.650.540.140.470.14-0.240.49-0.250.490.48-0.63-0.90.66-0.650.93-0.84-0.89
0.630.020.880.570.83-0.930.930.94-0.610.920.720.970.890.570.980.550.980.480.37-0.290.62-0.610.23-0.78-0.83
0.760.20.640.770.61-0.020.20.650.160.250.490.370.650.770.350.760.35-0.630.370.7-0.160.16-0.780.20.21
0.420.20.090.460.030.62-0.290.020.77-0.330.04-0.250.090.46-0.30.47-0.3-0.9-0.290.7-0.780.77-0.80.820.73
-0.01-0.110.3-0.050.4-0.80.480.46-0.80.610.250.60.31-0.050.68-0.080.680.660.62-0.16-0.78-0.80.47-0.92-0.74
0.010.11-0.350.05-0.40.77-0.42-0.411.0-0.53-0.33-0.5-0.350.05-0.540.08-0.54-0.65-0.610.160.77-0.8-0.350.860.73
-0.33-0.18-0.09-0.36-0.12-0.520.44-0.06-0.350.34-0.060.26-0.09-0.360.28-0.370.280.930.23-0.78-0.80.47-0.35-0.62-0.72
-0.10.12-0.46-0.05-0.490.95-0.71-0.560.86-0.76-0.4-0.74-0.47-0.05-0.79-0.02-0.79-0.84-0.780.20.82-0.920.86-0.620.94
-0.20.1-0.54-0.14-0.50.96-0.86-0.60.73-0.82-0.46-0.8-0.55-0.14-0.82-0.12-0.82-0.89-0.830.210.73-0.740.73-0.720.94
Click cells to compare fundamentals

Vincerx Pharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.14)
Return On Assets
(0.66)
Return On Equity
(1.42)
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.